Table 2.
Relationship Between Glypican-1 expression and Immunohistochemical Markers
| Immunohistochemical Marker | Low | Moderate | Strong | P value |
|---|---|---|---|---|
| AR | ||||
| Positive (n=121, 55%) | 15 (12.4%) | 28 (23.1%) | 78 (64.5%) | 0.323 |
| Negative (n=99, 45%) | 10 (10.1%) | 16 (16.2%) | 73 (73.7%) | |
| ER | ||||
| Positive (n=125, 56.8%) | 14 (11.2%) | 29 (23.2%) | 82 (65.6%) | 0.391 |
| Negative (n=95, 43.2%) | 11 (11.6%) | 15 (15.8%) | 69 (72.6%) | |
| PR | ||||
| Positive (n=100, 45.5%) | 11 (11%) | 23 (23%) | 66 (66%) | 0.597 |
| Negative (n=120, 54.5%) | 14 (11.7%) | 21 (17.5%) | 85 (70.8%) | |
| EGFR | ||||
| Positive (n=41, 18.6%) | 6 (14.6%) | 7 (17.1%) | 28 (68.3%) | 0.708 |
| Negative (n=179, 81.4%) | 19 (10.6%) | 37 (20.7%) | 123 (68.7%) | |
| HER2 | ||||
| Positive (n=157, 71.4%) | 18 (11.5%) | 34 (21.7%) | 105 (66.9%) | 0.605 |
| Negative (n=63, 28.6%) | 7 (11.1%) | 10 (15.9%) | 64 (73%) | |
| P53 | ||||
| Positive (n=156, 70.9%) | 20 (12.8%) | 28 (17.9%) | 108 (69.2%) | 0.340 |
| Negative (n=64, 29.1%) | 5 (7.8%) | 16 (25%) | 43 (67.2%) | |
| Ki-67 | ||||
| < 14% (n=111, 50.5%) | 31 (11.9%) | 21 (19.3%) | 75 (68.8%) | 0.942 |
| > 14% (n=109, 49.5%) | 12 (10.8%) | 23 (20.7%) | 76 (68.5%) |